BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8372617)

  • 21. Rh hemolytic disease of the newborn--the disease eradicated by immunology.
    Zipursky A
    Clin Obstet Gynecol; 1977 Sep; 20(3):759-72. PubMed ID: 408069
    [No Abstract]   [Full Text] [Related]  

  • 22. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 24. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.
    Sonneveld ME; Koelewijn J; de Haas M; Admiraal J; Plomp R; Koeleman CA; Hipgrave Ederveen AL; Ligthart P; Wuhrer M; van der Schoot CE; Vidarsson G
    Br J Haematol; 2017 Feb; 176(4):651-660. PubMed ID: 27891581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns.
    Gurevich P; Erina S; Gershon S; Zusman I
    Hum Antibodies; 1997; 8(2):76-89. PubMed ID: 9289392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Functional evaluation of erythrocytic antibodies by photometric detection of erythrophagocytosis in the monocyte monolayer assay].
    Cassens U; Garritsen HS; Sibrowski W; Holzgreve W
    Geburtshilfe Frauenheilkd; 1996 Jun; 56(6):297-300. PubMed ID: 8766487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-D concentration in mother and child in haemolytic disease of the newborn.
    Hughes-Jones NC; Ivona M; Ellis J; Walker W
    Vox Sang; 1971 Aug; 21(2):135-40. PubMed ID: 5000958
    [No Abstract]   [Full Text] [Related]  

  • 32. Monocyte monolayer assay (MMA)--an efficient method for predicting the clinical significance of alloantibodies and the severity of hemolytic disease of the newborn.
    Garratty G
    Beitr Infusionsther; 1988; 21():236-9. PubMed ID: 2462981
    [No Abstract]   [Full Text] [Related]  

  • 33. [Incidence of the detection of erythrocyte antibodies in relation to screening test cells].
    Heim MU; Alraun K; Leeping M; Schwarzfischer G; Böck M; Kling A; Mempel W
    Beitr Infusionsther; 1992; 30():443-5. PubMed ID: 1284756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Severe bleeding in a patient with anti-c alloantibodies and a rare Rhesus phenotype treated with compatible erythrocyte concentrate from the blood bank of the Council of Europe].
    Sonke GS; Overbeeke MA; de Graaff WE; Elisen MG
    Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2628-32. PubMed ID: 16355576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemolytic disease of the newborn caused by anti-MUT (MNS 35).
    van den Bos AG; Steiner K
    Vox Sang; 2004 Oct; 87(3):208-9. PubMed ID: 15569075
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemolytic disease of the newborn because of rare anti-Vel.
    van Gammeren AJ; Overbeeke MA; Idema RN; van Beek RH; Ten Kate-Booij MJ; Ermens AA
    Transfus Med; 2008 Jun; 18(3):197-8. PubMed ID: 18598283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immune destruction of red cells.
    Engelfriet CP
    Transfus Med; 1992 Mar; 2(1):1-6. PubMed ID: 1308459
    [No Abstract]   [Full Text] [Related]  

  • 38. Alloimmunity to RhD in humans.
    Urbaniak SJ
    Transfus Clin Biol; 2006; 13(1-2):19-22. PubMed ID: 16574456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe intrauterine hemolysis due to anti-C(w).
    Chu HP; Kanagalingam D; Chan DK
    Am J Perinatol; 2007 Nov; 24(10):623-6. PubMed ID: 17972235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of recombinant human erythropoietin (EPO-alfa) in a mother alloimmunized to the Js(b) antigen.
    Santolaya-Forgas J; Vengalil S; Duval J; Gottmann D; Meyer W; Gauthier D; DeChristopher PJ
    J Matern Fetal Med; 1999; 8(3):141-5. PubMed ID: 10338071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.